Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...

APPS's bull thesis hinges on stabilizing ODS and growing the advertisement segment, leveraging high gross margins in DTX despite lower R&D investments. APPS's shift from waterfall to SDK bidding ...

Download our guide to the digital therapeutics landscape, key providers, and market trends. Discover how digital health solutions can enhance pharmaceutical outcomes.

Hyfe’s CEO Tamsin Chislett spoke with Pharmaceutical Executive about this new technology, along with how digital therapeutics ...

The Global Digital Therapeutics Market is valued at USD 7.95 Billion in 2024 and is projected to reach a value of USD 75.71 ...

Currently, DTX is worth just $0.18, an 800% rise from its starting value of $0.02. This altcoin price will surge by another 100% to $0.36 after a Tier-1 CEX lists it soon. In other words, anyone ...

The digital therapeutics (DTx) market is experiencing significant growth with a projected CAGR of 25-27% over the next few ...

DTX Exchange (DTX) is one of the new players launching with so much disruptive potential, as it seeks to unite multi-trillion-dollar financial markets. Imagine one platform where you can trade top ...

Bowers & Wilkins supplies the sound system for the new Aston Martin Vanquish. The British hi-fi maker produces some of the ...

The V12-powered DB11 AMR will soon get a V8-engined successor, although it's not clear if the hotter DB12 will also bear the ...

Learn more about whether Envista Holdings Corporation or Penumbra, Inc. is a better investment based on AAII's A+ Investor ...